← Open Payments lookup

SCOTT ZELA: Open Payments

NPI 1326044306 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$14,500 in 99 payments from 12 companies in 2025. Trend: 2023 $1,382 · 2024 $7,479 · 2025 $14,500

Speaker / faculty: $8,640Travel & lodging: $3,737Food & beverage: $1,718Consulting: $405
CompanyPaymentsAmount
Madrigal Pharmaceuticals30$13,045
Salix Pharmaceuticals, a division of Bausch Health US, LLC23$361
Gilead Sciences, Inc.12$343
Ipsen Biopharmaceuticals, Inc15$335
ABBVIE INC.8$174
Takeda Pharmaceuticals U.S.A., Inc.4$96
ORPHALAN INC2$36
Mallinckrodt Hospital Products Inc.1$33
Mirum Pharmaceuticals, Inc.1$22
VIVUS LLC1$21

Products named: REZDIFFRA, XIFAXAN, IQIRVO, LIVTENCITY, MAVYRET, CREON, CUVRIOR, TERLIVAZ.

Industry payments across TX — which companies pay providers there.